 |
 |
Just going back over some old postings and wondered: 1. What happened to the transdermal patch? A May 13 1997 annoucement "Discovery and Yoshimtomi sign Japanese Parkinson patch deal" which licensed their transdermal patch of N-0923 a novel dopamine agonist which at the time had progressed past Phase 2b clinical trials. 2. What are the current feelings/research into the use of Clozapine for hallucinations in PD? 3. Has Olanzapine taken over from Clozapine as the drug of choice? Left wondering Joy Graham